Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples